Advanced Filter

Filter by Group

Filter by Market Availability

Did you mean 3,4 39 2?
Displaying drugs 11626 - 11650 of 12539 in total
Vet approved
Matched Iupac: … methyl N-(6-propoxy-1,3-benzothiazol-2-yl)carbamate …
Experimental
Matched Iupac: … 2-(2,2-diphenylacetyl)-2,3-dihydro-1H-indene-1,3-dione …
Experimental
Matched Iupac: … (2S,4R)-1-acetyl-4-hydroxypyrrolidine-2-carboxylic acid …
Experimental
Matched Iupac: … [3-(2-chloro-10H-phenothiazin-10-yl)propyl]diethylamine …
Matched Categories: … Heterocyclic Compounds, 3-Ring …
Experimental
Matched Iupac: … 3-chloro-4-(3-chloro-2-nitrophenyl)-1H-pyrrole …
Investigational
Matched Iupac: … 2-[(6-chloropyridazin-3-yl)sulfanyl]-N,N-diethylacetamide …
Cavosonstat is under investigation in clinical trial NCT02589236 (Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation).
Investigational
Matched Iupac: … 3-chloro-4-(6-hydroxyquinolin-2-yl)benzoic acid …
Motexafin lutetium (MLu) is a second-generation photosensitizer for photodynamic therapy (PDT) of cancer. It belongs to the family of drugs called metallotexaphyrins. Also called lutetium texaphyrin. Motexafin lutetium is a pentadentate aromatic metallotexaphyrin with photosensitizing properties.
Investigational
Matched Iupac: … lutetium(3+) 4,5-diethyl-9,24-bis(3-hydroxypropyl)-16,17-bis({2-[2-(2-methoxyethoxy)ethoxy]ethoxy})-10,23 …
Motexafin gadolinium is studied in the treatment of cancer by Pharmacyclics. It may make tumor cells more sensitive to radiation therapy, improve tumor images using magnetic resonance imaging (MRI), and kill cancer cells. It belongs to the family of drugs called metalloporphyrin complexes. Also called gadolinium texaphyrin.
Investigational
Matched Iupac: … gadolinium(3+) 4,5-diethyl-9,24-bis(3-hydroxypropyl)-16,17-bis({2-[2-(2-methoxyethoxy)ethoxy]ethoxy}) …
Experimental
Illicit
Matched Iupac: … ethyl 1-[2-(benzyloxy)ethyl]-4-phenylpiperidine-4-carboxylate …
Experimental
Matched Iupac: … (2S)-2-amino-4-oxo-4-(phosphonooxy)butanoic acid …
Experimental
Matched Iupac: … (2S,3S,4R,5S)-2-(hydroxymethyl)oxane-2,3,4,5-tetrol …
Experimental
Matched Iupac: … 2-imino-3-(1H-indol-3-yl)propanoic acid …
Experimental
Matched Iupac: … 2-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)acetic acid …
Experimental
Matched Iupac: … 1,3-bis(4-amino-2-methylquinolin-6-yl)urea …
Investigational
Matched Iupac: … 1-phenyl-2-(pyrrolidin-1-yl)nonan-1-one …
Investigational
Matched Iupac: … N-carbamimidoyl-3-methanesulfonyl-4-(propan-2-yl)benzamide …
Matched Salts cas: … 159138-81-5
Investigational
Matched Iupac: … 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine …
Clobutinol is a cough suppressant that is withdrawn from the US and EU markets. Clobutinol may prolong the QT interval. In 2007, Clobutinol was determined to cause cardiac arrhythmia in some patients.
Withdrawn
Matched Iupac: … 1-(4-chlorophenyl)-4-(dimethylamino)-2,3-dimethylbutan-2-ol …
Methyl undecenoyl leucinate is an active ingredient in whitening creams. It is an α-MSH antagonist that inhibits melanin synthesis and tyrosinase activity and reduces expression of various melanogenic genes.
Experimental
Matched Iupac: … methyl (2S)-4-methyl-2-(undec-10-enamido)pentanoate …
Ricolinostat is under investigation for the treatment of Breast Carcinoma and Metastatic Breast Cancer.
Investigational
Matched Iupac: … 7-{[2-(diphenylamino)pyrimidin-5-yl]formamido}-N-hydroxyheptanamide …
Clorindione is a vitamin K antagonist, which may be useful to decrease prothrombin levels in humans.
Experimental
Matched Iupac: … 2-(4-chlorophenyl)-2,3-dihydro-1H-indene-1,3-dione …
Experimental
Matched Iupac: … N-benzyl-N-[2-(pyrrolidin-1-yl)ethyl]aniline …
Experimental
Matched Iupac: … 1-(tert-butylamino)-3-(2,5-dichlorophenoxy)propan-2-ol …
Matched Salts cas: … 54247-25-5
Experimental
Matched Iupac: … 4-{2-[4-(4-chlorobenzoyl)-2,6-dimethoxyphenoxy]ethyl}morpholine …
Displaying drugs 11626 - 11650 of 12539 in total